Effects of Mindfulness Meditation in Virtual Reality on Craving and Smoking Cessation
Key facts
- Who runs it
- Centre Hospitalier Henri Laborit
- Where
- France3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 15 Jun 2023
- Expected to end
- 15 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Virtual reality pod
- nicotine patches and chewing gum
- Record updated
- 13 January 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Any patient consuming 10 to 40 cigarettes per day
- Woman or man aged 18 to 75 inclusive
- Substance use disorder according to the DSM5 classification
- Benefit from social security or benefit from it through a third party in accordance with French law on research involving the human person
- Having signed the informed consent form after having received written information
Who cannot take part
- Disabling cognitive disorders
- Patient with a psychological disorder or a psychiatric pathology requiring specialized follow-up
- Advanced pulmonary, renal, and hepatic diseases, or any unstable and serious medical conditions that could compromise the patient's participation in the study, subject to the judgment of the doctor
- Patient allergic to a molecule present in nicotine substitutes
- Patient under 18 or over 75 years old
- Patient with addiction to another product
- Cardiological pathologies that could compromise the participation of patients, detected by an ECG (only for patients who will be randomized in the experimental group)
- Pregnant or breastfeeding woman
- Simultaneous participation in another trial
- Employee of the investigator or of the clinical trial site
- Patients protected by law
- Patients who do not speak the French language
- People not covered by state health insurance
- Patients who in the opinion of the investigator are unable to complete the questionnaires
- Patient claustrophobic or anxious about using the cabin
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
This trial is currently available in France.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Investigators seek to propose a non-drug therapeutic alternative, namely a mindfulness meditation protocol based on virtual reality training in order to induce progressive modifications of various indicators of craving.
Read full original descriptionShow less
The study hypothesis is that the practice of mindfulness meditation in a virtual reality environment reduces the craving induced by cues and stress and therefore ultimately smoking relapse.
The main objective of the protocol will be to demonstrate that mindfulness meditation can reduce long-term relapse (continuous cessation (> 30 days) of smoking cessation).
The participants will be randomized into two groups: the experimental group will perform six virtual reality sessions in a multisensory cabin at the rate of one session per week; the control group will be prescribed the gold standard treatment (nicotine patches and chewing gum).
Participants will be seen again at three and six months to assess whether or not there has been a smoking relapse.
The 2 groups in the trial
- Interventional GroupTreatment being tested
Patients in this arm will have 6 sessions of virtual reality in a pod (1 session per week). Patients will then have a visit at day 90 and day 180.
Treatment: Virtual reality pod
- Control groupExisting treatment, for comparison
Patients in this arm will receive the gold standard of treatment for tobacco cessation (nicotine patches and chewing gum) from day 0 (inclusion visit) to day 90. Patients will then have a visit at day 90 and day 180.
Treatment: nicotine patches and chewing gum
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT05766553, who can take part
- Record updated
- 13 January 2026